119 related articles for article (PubMed ID: 24088697)
1. Chemistry of ecteinascidins. Part 4: preparation of 2'-N-acyl ecteinascidin 770 derivatives with improved cytotoxicity profiles.
Tsujimoto M; Lowtangkitcharoen W; Mori N; Pangkruang W; Putongking P; Suwanborirux K; Saito N
Chem Pharm Bull (Tokyo); 2013; 61(10):1052-64. PubMed ID: 24088697
[TBL] [Abstract][Full Text] [Related]
2. Chemistry of ecteinascidins. Part 3: preparation of 2'-N-acyl derivatives of ecteinascidin 770 and evaluation of cytotoxicity.
Saktrakulkla P; Toriumi S; Tsujimoto M; Patarapanich C; Suwanborirux K; Saito N
Bioorg Med Chem; 2011 Aug; 19(15):4421-36. PubMed ID: 21752654
[TBL] [Abstract][Full Text] [Related]
3. Chemistry of Ecteinascidins. Part 5: An Additional Proof of Cytotoxicity Evaluation of Ecteinascidin 770 Derivatives.
Toyoshima R; Mori N; Suzuki T; Lowtangkitcharoen W; Suwanborirux K; Saito N
Chem Pharm Bull (Tokyo); 2016; 64(7):966-9. PubMed ID: 27373655
[TBL] [Abstract][Full Text] [Related]
4. Chemistry of ecteinascidins. Part 2. Preparation of 6'-O-acyl derivatives of stable ecteinascidin and evaluation of cytotoxicity.
Puthongking P; Patarapanich C; Amnuoypol S; Suwanborirux K; Kubo A; Saito N
Chem Pharm Bull (Tokyo); 2006 Jul; 54(7):1010-6. PubMed ID: 16819221
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumor activity of simplified ecteinascidin-saframycin analogs.
Liu ZZ; Wang Y; Tang YF; Chen SZ; Chen XG; Li HY
Bioorg Med Chem Lett; 2006 Mar; 16(5):1282-5. PubMed ID: 16338237
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues.
Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C
Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of isoquinolinone-based tetracycles as poly (ADP-ribose) polymerase-1 (PARP-1) inhibitors.
Rhee HK; Lim SY; Jung MJ; Kwon Y; Kim MH; Choo HY
Bioorg Med Chem; 2009 Nov; 17(21):7537-41. PubMed ID: 19800803
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of the ABH rings of ecteinascidin 597 using a connective Pummerer-type cyclisation.
Smith LH; Nguyen TT; Sneddon HF; Procter DJ
Chem Commun (Camb); 2011 Oct; 47(38):10821-3. PubMed ID: 21863175
[TBL] [Abstract][Full Text] [Related]
9. Lamellarin D bioconjugates I: Synthesis and cellular internalization of PEG-derivatives.
Pla D; Francesch A; Calvo P; Cuevas C; Aligué R; Albericio F; Alvarez M
Bioconjug Chem; 2009 Jun; 20(6):1100-11. PubMed ID: 19472995
[TBL] [Abstract][Full Text] [Related]
10. Ecteinascidins 770 and 786 from the Thai tunicate Ecteinascidia thurstoni.
Suwanborirux K; Charupant K; Amnuoypol S; Pummangura S; Kubo A; Saito N
J Nat Prod; 2002 Jun; 65(6):935-7. PubMed ID: 12088444
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship study of potent cytotoxic analogues of the marine alkaloid Lamellarin D.
Pla D; Marchal A; Olsen CA; Francesch A; Cuevas C; Albericio F; Alvarez M
J Med Chem; 2006 Jun; 49(11):3257-68. PubMed ID: 16722644
[TBL] [Abstract][Full Text] [Related]
12. Advances in the chemistry and pharmacology of ecteinascidins, a promising new class of anti-cancer agents.
Manzanares I; Cuevas C; García-Nieto R; Marco E; Gago F
Curr Med Chem Anticancer Agents; 2001 Nov; 1(3):257-76. PubMed ID: 12678757
[TBL] [Abstract][Full Text] [Related]
13. The potent anticancer compound ecteinascidin-743 (ET-743) as its 2-propanol disolvate.
Sainz-Diaz CI; Manzanares I; Francesch A; Garcia-Ruiz J
Acta Crystallogr C; 2003 Apr; 59(Pt 4):O197-8. PubMed ID: 12682407
[TBL] [Abstract][Full Text] [Related]
14. Chemistry of Renieramycins. 15. Synthesis of 22-O-Ester Derivatives of Jorunnamycin A and Their Cytotoxicity against Non-Small-Cell Lung Cancer Cells.
Sirimangkalakitti N; Chamni S; Charupant K; Chanvorachote P; Mori N; Saito N; Suwanborirux K
J Nat Prod; 2016 Aug; 79(8):2089-93. PubMed ID: 27487087
[TBL] [Abstract][Full Text] [Related]
15. Lamellarin D bioconjugates II: Synthesis and cellular internalization of dendrimer and nuclear location signal derivatives.
Pla D; Martí M; Farrera-Sinfreu J; Pulido D; Francesch A; Calvo P; Cuevas C; Royo M; Aligué R; Albericio F; Alvarez M
Bioconjug Chem; 2009 Jun; 20(6):1112-21. PubMed ID: 19472996
[TBL] [Abstract][Full Text] [Related]
16. Synthetic studies on ecteinascidin-743: constructing a versatile pentacyclic intermediate for the synthesis of ecteinascidins and saframycins.
Jin W; Metobo S; Williams RM
Org Lett; 2003 Jun; 5(12):2095-8. PubMed ID: 12790537
[TBL] [Abstract][Full Text] [Related]
17. Discovery of N-substituted 3-arylisoquinolone derivatives as antitumor agents originating from O-substituted 3-arylisoquinolines via [2,3] or [3,3] rearrangement.
Li B; Wang G; Xu Z; Zhang Y; Huang X; Zeng B; Chen K; Shi J; Wang H; Zhu W
Eur J Med Chem; 2014 Apr; 77():204-10. PubMed ID: 24637214
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity of new pyrazino[1,2-b]isoquinoline and 6,15-iminoisoquino[3,2-b]3-benzazocine compounds.
Ortín I; González JF; de la Cuesta E; Avendaño C
Bioorg Med Chem; 2010 Sep; 18(18):6813-21. PubMed ID: 20709558
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and topoisomerase I inhibitory activity of a novel diazaindeno[2,1-b]phenanthrene analogue of Lamellarin D.
Cananzi S; Merlini L; Artali R; Beretta GL; Zaffaroni N; Dallavalle S
Bioorg Med Chem; 2011 Aug; 19(16):4971-84. PubMed ID: 21783369
[TBL] [Abstract][Full Text] [Related]
20. Additional antitumor ecteinascidins from a Caribbean tunicate: crystal structures and activities in vivo.
Sakai R; Rinehart KL; Guan Y; Wang AH
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11456-60. PubMed ID: 1454834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
